Hennion & Walsh Asset Management, Inc. Corcept Therapeutics Inc Transaction History
Hennion & Walsh Asset Management, Inc.
- $1.89 Billion
- Q2 2024
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 59,489 shares of CORT stock, worth $2.7 Million. This represents 0.1% of its overall portfolio holdings.
Number of Shares
59,489
Previous 54,869
8.42%
Holding current value
$2.7 Million
Previous $1.38 Million
39.8%
% of portfolio
0.1%
Previous 0.08%
Shares
9 transactions
Others Institutions Holding CORT
# of Institutions
311Shares Held
88.3MCall Options Held
1.07MPut Options Held
973K-
Black Rock Inc. New York, NY16.5MShares$751 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.55MShares$434 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.24MShares$374 Million11.51% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.91MShares$314 Million0.4% of portfolio
-
Parallel Advisors, LLC3.82MShares$173 Million3.2% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $4.87B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...